Himension Capital Singapore PTE. LTD. Raises Stock Holdings in Lam Research Corporation $LRCX

Himension Capital Singapore PTE. LTD. increased its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 5.1% during the 1st quarter, Holdings Channel reports. The firm owned 50,858 shares of the semiconductor company’s stock after purchasing an additional 2,469 shares during the quarter. Lam Research comprises approximately 0.8% of Himension Capital Singapore PTE. LTD.’s portfolio, making the stock its 23rd biggest holding. Himension Capital Singapore PTE. LTD.’s holdings in Lam Research were worth $10,866,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of LRCX. Cedar Mountain Advisors LLC grew its position in Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 85 shares in the last quarter. Vermillion Wealth Management Inc. bought a new position in Lam Research in the first quarter valued at $26,000. Bayban purchased a new stake in Lam Research during the fourth quarter valued at about $26,000. Mcguire Capital Advisors Inc. purchased a new stake in Lam Research during the fourth quarter valued at about $27,000. Finally, Core Wealth Advisors LLC bought a new stake in Lam Research during the fourth quarter worth about $29,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

Insider Buying and Selling

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 104,621 shares of company stock worth $33,804,737. Company insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Barclays reiterated an “overweight” rating and issued a $335.00 price objective (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. Mizuho boosted their target price on Lam Research from $380.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft upped their target price on Lam Research from $300.00 to $325.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. Wells Fargo & Company reiterated an “overweight” rating and set a $450.00 price target (up from $365.00) on shares of Lam Research in a research report on Monday, June 22nd. Finally, Sanford C. Bernstein lifted their price target on shares of Lam Research from $325.00 to $340.00 and gave the stock an “outperform” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $360.51.

Get Our Latest Report on LRCX

Lam Research Stock Up 5.0%

Shares of NASDAQ:LRCX opened at $322.00 on Wednesday. The stock has a market capitalization of $402.68 billion, a P/E ratio of 60.75, a price-to-earnings-growth ratio of 1.82 and a beta of 1.80. The stock’s 50-day moving average price is $340.44 and its 200-day moving average price is $271.60. The company has a current ratio of 2.54, a quick ratio of 1.77 and a debt-to-equity ratio of 0.35. Lam Research Corporation has a 12-month low of $90.93 and a 12-month high of $438.50.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.11. The company had revenue of $5.84 billion during the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.Lam Research’s revenue for the quarter was up 23.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.04 EPS. On average, equities analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were given a $0.26 dividend. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 annualized dividend and a yield of 0.3%. Lam Research’s payout ratio is presently 19.62%.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Recommended Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.